Lifting the lid on a brain longevity data platform

Dr Owen Phillips on incorporating imaging, genetics and demographics into a meaningful patient experience.

BrainKey?is pioneering an approach to brain longevity which quantifies brain health and aligns patients with personal treatment recommendations – a brain longevity data platform.

My take on this: We?recently featured BrainKey?as a Neurotech Trailblazer in?our recent report?and our curiosity was piqued.?BrainKey’s?platform applies AI to brain imaging and genetic data to provide actionable brain health insights. To find out more, we sat down with Owen Phillips, PhD, BrainKey’s founder and CEO.

The key, according to Phillips, is biology.

Biology drives brain longevity, but biology of course, is complex, with a multitude of drivers, pathways and reactions pulling in myriad directions. And biology is even more complicated in the brain.

“Until now, it has been too difficult to understand an individual patient’s underlying brain biology,” explains Phillips. “This has forced the field to rely on external observable symptoms. This approach is error prone. The problem is that even in patients with very similar external symptoms, the underlying biology driving their symptoms can be different.

"We’re working hard to unlock the brain’s biology at a patient level. At BrainKey we are building AI tools that unlock each patient’s personal brain biology. We do this so that we can help patients get the right treatment to extend their brain longevity.”

Read the full article HERE.

Thanks for reading! If you’ve enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!